These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36503460)

  • 1. Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression
    Chen Y; Zhang J; Wei S
    Curr Pharm Biotechnol; 2023; 24(10):1335-1342. PubMed ID: 36503460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
    Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
    Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.
    Piromkraipak P; Sangpairoj K; Tirakotai W; Chaithirayanon K; Unchern S; Supavilai P; Power C; Vivithanaporn P
    Cell Mol Neurobiol; 2018 Mar; 38(2):559-573. PubMed ID: 28600709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
    Henderson WR; Chiang GK; Tien YT; Chi EY
    Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes and cells from lung cancer pleural exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
    Lukic A; Wahlund CJE; Gómez C; Brodin D; Samuelsson B; Wheelock CE; Gabrielsson S; Rådmark O
    Cancer Lett; 2019 Mar; 444():1-8. PubMed ID: 30508568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast reduces seizures in pentylenetetrazol-kindled mice.
    Fleck J; Temp FR; Marafiga JR; Jesse AC; Milanesi LH; Rambo LM; Mello CF
    Braz J Med Biol Res; 2016; 49(4):e5031. PubMed ID: 26909785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene E
    Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
    J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M; Rovati GE; Cavanillas AB
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
    Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human cysteinyl leukotriene CysLT1 receptor.
    Lynch KR; O'Neill GP; Liu Q; Im DS; Sawyer N; Metters KM; Coulombe N; Abramovitz M; Figueroa DJ; Zeng Z; Connolly BM; Bai C; Austin CP; Chateauneuf A; Stocco R; Greig GM; Kargman S; Hooks SB; Hosfield E; Williams DL; Ford-Hutchinson AW; Caskey CT; Evans JF
    Nature; 1999 Jun; 399(6738):789-93. PubMed ID: 10391245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19.
    Dey M; Singh RK
    Pharmacology; 2021; 106(9-10):469-476. PubMed ID: 34350893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells.
    Tsai MJ; Chang WA; Tsai PH; Wu CY; Ho YW; Yen MC; Lin YS; Kuo PL; Hsu YL
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
    Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; inoue A; Nakao T; Nomura H; Murata M; Nakao S; Nambu F; Fujita M; Nakade S; Kawabata K
    Eur J Pharmacol; 2015 Oct; 765():242-8. PubMed ID: 26318198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
    Sekioka T; Kadode M; Fujii M; Kawabata K; Abe T; Horiba M; Kohno S; Nabe T
    Allergol Int; 2015 Oct; 64(4):351-8. PubMed ID: 26433531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
    Di Gennaro A; Araújo AC; Busch A; Jin H; Wågsäter D; Vorkapic E; Caidahl K; Eriksson P; Samuelsson B; Maegdefessel L; Haeggström JZ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1907-1912. PubMed ID: 29432192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.